28800sek
-1,5 %
Date:2025-07-07Time:18:00:00Latest report:Q1-2025List:Mid CapTicker:XVIVO
Market Cap:9 072 msekEnterprise Value:8 785 msekNet Sales:855,0 msekEarnings:137,0 msekEmployees:0ISIN:SE0004840718

Ratios

10-year key figure history for Xvivo Perfusion turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Xvivo Perfusion with index and moving average MA50 and MA200.

Stockprice:288,00
MA50:303,87
MA200:406,64
Price/MA200:-29,2 %
RSI (14):47,7
Price/MA50:-5,2 %

Description

Xvivo Perfusion operates in the medical technology industry and focuses on the development and manufacturing of systems for organ transplantation and perfusion. Examples of products that the company supplies include cannulas, organ storage and cooling solutions. The company's products are aimed at healthcare institutions and surgeons. Xvivo Perfusion operates globally, was founded in 1998 and is headquartered in Gothenburg, Sweden.

Medical Equipment